Investors love Teva’s new CEO, but falling generic drug prices will weigh on shares -- Heard on the Streethttp://on.wsj.com/2xgBva2
0 replies
11 retweets
16 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.